Ajanta Pharma share news, announcements and annual reports
NSE: AJANTPHARMBSE: 532331Pharmaceuticals & BiotechnologyMid Cap
Ajanta Pharma Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 2000 on NSE, Jun 2000 on BSE
Last close ₹3,459.80up ₹106.20 (3.17%)BSE ₹3,451.70
Share price at the NSE close on 28 Oct 2026. Previous close ₹3,353.60.
28 Oct: open ₹3,354.00, high ₹3,516.40, low ₹3,342.90
52-week range of traded prices to 28 Oct 2026
₹2,382.00Low, 28 Oct 2025₹3,796.00High, 18 Aug 2026
- Next results date: the board meets on 30 Oct 2026 to consider: financial results. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹43,233 Cr236th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 38.10
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 9.55
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.73%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 27.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.05
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 43,73334.1% delivered
Ajanta Pharma share news and announcements
810 announcements, routine notices left out, newest first. Page 17 of 17.
Jul 2007
30 Jul · Business
Press release dated July 30, 2007, titled "Ajanta Pharma Continues Growth in Q1 Profit After Tax up 77%". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Jul · Corporate action
Company shall close its Equity Share Transfer Books for a period from September 21, 2007 to September 28, 2007 (both days inclusive). The said Book Closure is for declaration of dividend. The Board has recommended dividend @ 20% to be paid to the shareholders if the same is approved by the shareholders in the Annual General Meeting to be held on September 28, 2007.19 Jul · Board meeting
Meeting on 30 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”
Apr 2007
27 Apr · Business
Press release dated April 27, 2007, titled "Ajanta Pharma Net Profit Up 32%". The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.27 Apr · Meeting
Board of Directors at its, Meeting held on April 27, 2007 have recommended the dividend @Rs.2.00 per share, subject to the approval of the shareholders at the ensuing Annual General Meeting to be held on September 28, 2007.18 Apr · Board meeting
To consider and approve, inter alia, the audited financial results for the year ended March 31, 2007 and recommending dividend, if any, on equity shares of the Company for the Financial Year 2006 -07.
Mar 2007
8 Mar · Limited Review Report
Auditors have conducted the limited review for the unaudited financial results for the quarter ended on December 31, 2006. The details of the limited review shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jan 2007
30 Jan · Business
Press release, dated January 30, 2007, titled "Ajanta Pharma's net profit grows 25%." The details of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Jan · Board meeting
Meeting on 30 Jan 2007: “Unaudited Financial Results for the quarter ended Dec 31, 06”12 Jan · Management
Mr. O. P. Singh, has resigned from the Secretaryship w.e.f. 31st August, 2006 and Mr. C. Napoleon has joined in his place as Company Secretary w.e.f. 20th December, 2006